OS Therapies（OSTX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他75.66%
个人与内部人士11.99%
机构投资者6.28%
私营企业6.07%

主要股东

主要股东最新
股东
Shalom Auerbach	5.80%	267.76 万	1.01%	+0	2025/07/29
Paul RomnessFounder, Chairman, President & CEO	5.36%	247.30 万	0.93%	+0	2026/01/22
Ayala Pharmaceuticals, Inc.	4.69%	216.42 万	0.82%	+0	2025/08/20
Vanguard Capital Management, LLC	2.06%	95.18 万	0.57%	+36.57 万	2026/06/30
Mill River Partners LLC	0.94%	43.58 万	0.16%	+0	2026/01/22
CM Management, LLC	0.87%	40.00 万	0.15%	+0	2026/06/30
Geode Capital Management, LLC	0.65%	30.18 万	0.06%	+2.17 万	2026/06/30
Howard Financial Services, Ltd.	0.54%	24.80 万	0.09%	+2,565.00	2026/06/30
BlackRock, Inc.	0.53%	24.25 万	0.36%	+17.77 万	2026/06/30
Robert PetitChief Medical Officer & Chief Scientific Officer	0.43%	20.00 万	0.08%	+0	2026/01/22
Stateside Developments Limited	0.43%	19.89 万	0.08%	+0	2024/12/31
State Street Investment Management	0.26%	12.01 万	0.03%	+2.89 万	2026/06/30
Christopher AcevedoChief Financial Officer	0.24%	10.94 万	0.04%	+0	2026/01/22
Marshall Wace LLP	0.22%	10.06 万	0.22%	+10.06 万	2026/06/30
HighTower Advisors, LLC	0.19%	8.56 万	0.15%	+7.04 万	2026/06/30
Northern Trust Global Investments	0.15%	7.08 万	0.01%	+4,763.00	2026/06/30
Beacon Pointe Advisors, LLC	0.14%	6.25 万	0.02%	+0	2026/06/30
Bridgeway Capital Management, LLC	0.10%	4.50 万	0.03%	+2.00 万	2026/06/30
Ingalls & Snyder, LLC	0.08%	3.67 万	0.01%	+0	2026/06/30
Two Sigma Investments, LP	0.07%	3.04 万	<0.01%	+4,034.00	2026/06/30